Literature DB >> 22372790

Hypoglycaemia: a little known effect of Venlafaxine overdose.

Marie-Catherine Francino1, Marie Bretaudeau Deguigne, Julie Badin, Alain Turcant, Dominique Perrotin.   

Abstract

We report the case of a 39-year-old woman who presented with serotonin syndrome and hypoglycaemia likely due to intoxication with a very high dose of venlafaxine. This case of venlafaxine-associated hypoglycaemia was treated first by glucose perfusion, but despite large doses, hypoglycaemia recurred. Blood glucose normalized after injection of octreotide, eliminating the need for hypertonic glucose. Octreotide has been shown to decrease glucose requirements and the number of hypoglycaemic episodes in patients with sulfonylurea-induced hypoglycaemia but, to our knowledge, its ability to resolve hypoglycaemic episodes due to massive venlafaxine overdose has not yet been described.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372790     DOI: 10.3109/15563650.2012.660696

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  3 in total

1.  Hypoglycemia in venlafaxine overdose: a hypothesis of increased glucose uptake.

Authors:  Miran Brvar; Gordana Koželj; Lucija Peterlin Mašič
Journal:  Eur J Clin Pharmacol       Date:  2014-11-20       Impact factor: 2.953

2.  Venlafaxine-induced hypoglycemia.

Authors:  Jane Kobylianskii; Peter E Wu
Journal:  CMAJ       Date:  2021-04-19       Impact factor: 8.262

3.  A Case Report of Rare Adverse Events Associated with Venlafaxine Administration: Hypoglycemia and Lactic Acidosis.

Authors:  Serdar Özdemir
Journal:  Korean J Fam Med       Date:  2021-11-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.